“AI in Medicine”的搜索结果，显示 201-210 项，共有 5349 项
... treatment of patients with chronic myelomonocytic leukemia that has come back (recurrent) or that does not respond to treatment (refractory). Onvansertib is ...
Page 1.
一份馈赠，无穷力量——今天就来伸出援手！ ... 您的捐赠可以抵税。请您慷慨解囊，和我们一起进行尖端研究和医护，共同推动医学的改变。
This phase III trial compares memantine to usual treatment in treating patients with brain tumors that are newly diagnosed or has come back (recurrent).
显示$起始范围- $结束范围/源自可用$可用医生. Lezlie H. Andersen, M.D.. Pediatric Hospitalist; Hospice and Palliative Medicine ...
Rochester, Minn. The purpose of this study is to evaluate the reduction in the peritoneal carcinomatosis index (PCI) after completion of the study treatment.
... treatment in patients with treatment-naive ALK-positive advanced NSCLC. Patients will be randomized in a 1:1 ratio to receive either alectinib, 600 mg ...
Share · Tweet; WeChat. WeChat. Close. Weibo. Feb. 22, 2023 . VID-20539285. 主页; Mayo Clinic Orthopedics and Sports Medicine Chronic Exertional Compartment ...
The New England Journal of Medicine. 2021; doi:10.1056/NEJMp2034334. Saleh A, et al. Vaccine development throughout history. Cureus. 2021; doi:10.7759 ...
妙佑医疗国际不为任何公司或产品背书。广告收入为我们的非营利使命提供支持。
浏览妙佑医疗国际出版社提供的畅销书以及书籍和简报的特别优惠。
您的捐赠可以抵税。请您慷慨解囊，和我们一起进行尖端研究和医护，共同推动医学的改变。